Wu WG - Search Results

1

TRAIL-R2 is not correlated with p53 status and is rarely mutated in non-small cell lung cancer.

Wu WG, Soria JC, Wang L, Kemp BL, Mao L. Wu WG, et al. Anticancer Res. 2000 Nov-Dec;20(6B):4525-9. Anticancer Res. 2000. PMID: 11205299

2

C-CAM1, a candidate tumor suppressor gene, is abnormally expressed in primary lung cancers.

Wang L, Lin SH, Wu WG, Kemp BL, Walsh GL, Hong WK, Mao L. Wang L, et al. Among authors: wu wg. Clin Cancer Res. 2000 Aug;6(8):2988-93. Clin Cancer Res. 2000. PMID: 10955775

3

Overexpression of cdc25A and cdc25B is frequent in primary non-small cell lung cancer but is not associated with overexpression of c-myc.

Wu W, Fan YH, Kemp BL, Walsh G, Mao L. Wu W, et al. Cancer Res. 1998 Sep 15;58(18):4082-5. Cancer Res. 1998. PMID: 9751615

4

Expression of DMBT1, a candidate tumor suppressor gene, is frequently lost in lung cancer.

Wu W, Kemp BL, Proctor ML, Gazdar AF, Minna JD, Hong WK, Mao L. Wu W, et al. Cancer Res. 1999 Apr 15;59(8):1846-51. Cancer Res. 1999. PMID: 10213490

5

Prognostic implication of microsatellite alteration profiles in early-stage non-small cell lung cancer.

Zhou X, Kemp BL, Khuri FR, Liu D, Lee JJ, Wu W, Hong WK, Mao L. Zhou X, et al. Clin Cancer Res. 2000 Feb;6(2):559-65. Clin Cancer Res. 2000. PMID: 10690539

6

FTSJ1 regulates tRNA 2'-O-methyladenosine modification and suppresses the malignancy of NSCLC via inhibiting DRAM1 expression.

He Q, Yang L, Gao K, Ding P, Chen Q, Xiong J, Yang W, Song Y, Wang L, Wang Y, Ling L, Wu W, Yan J, Zou P, Chen Y, Zhai R. He Q, et al. Cell Death Dis. 2020 May 11;11(5):348. doi: 10.1038/s41419-020-2525-x. Cell Death Dis. 2020. PMID: 32393790 Free PMC article.

7

Anomalies of the TGF-beta postreceptor signaling pathway in ovarian cancer cell lines.

Hu W, Wu W, Nash MA, Freedman RS, Kavanagh JJ, Verschraegen CF. Hu W, et al. Anticancer Res. 2000 Mar-Apr;20(2A):729-33. Anticancer Res. 2000. PMID: 10810347

8

Correction: FTSJ1 regulates tRNA 2'-O-methyladenosine modification and suppresses the malignancy of NSCLC via inhibiting DRAM1 expression.

He Q, Yang L, Gao K, Ding P, Chen Q, Xiong J, Yang W, Song Y, Wang L, Wang Y, Ling L, Wu W, Yan J, Zou P, Chen Y, Zhai R. He Q, et al. Cell Death Dis. 2020 Jun 3;11(6):418. doi: 10.1038/s41419-020-2623-9. Cell Death Dis. 2020. PMID: 32488007 Free PMC article.

9

Proteomics in cancer research.

Wu W, Hu W, Kavanagh JJ. Wu W, et al. Int J Gynecol Cancer. 2002 Sep-Oct;12(5):409-23. doi: 10.1046/j.1525-1438.2002.01200.x. Int J Gynecol Cancer. 2002. PMID: 12366655 Review.

10

Burden of biliary tract carcinoma in China (1990-2021): Findings from the 2021 Global Burden of Disease Study.

Zhang W, Wang YJ, Liu JM, Sun XH, Jiang Y, Shen F, Shen LJ, Xiang J, Zhang JF, Yang LH, Wu WG, Chen T, Wang H, He M, Liu LG, Tao WQ, Chen YZ, Xiang YB, Li ML, Zhou MG, Liu YB. Zhang W, et al. Among authors: wu wg. Sci Bull (Beijing). 2024 Nov 30;69(22):3547-3557. doi: 10.1016/j.scib.2024.09.026. Epub 2024 Sep 24. Sci Bull (Beijing). 2024. PMID: 39366826 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

179 results

Search Page

Filters